Stéphanie Tissot-Renaud

10PUBLICATIONS
149CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsTumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 17, 2026
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

|Mar 23, 2026
Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.

Athénaïs van der Elst, Daniel Herrero-Saboya, Lucas Michon

|Feb 10, 2026
Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.

Athénaïs van der Elst, Daniel Herrero-Saboya, Lucas Michon

|May 12, 2025
Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity.

Yixing Dong, Chiara Saglietti, Quentin Bayard

|Jan 31, 2025
Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma.

Mengzhu Sun, Laure Garnier, Romane Chevalier

|Oct 11, 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy.

Florian Huber, Marion Arnaud, Brian J Stevenson

Pageof 2